针对性抗癌药物的不可知性管理:在作和谨慎之间寻找平衡
Svetlana N Aleksakhina1, Alexander O Ivantsov1,2, Evgeny N Imyanitov1,2
1Department of Tumor Growth Biology, N. N. Petrov Institute of Oncology, 197758 St. Petersburg, Russia.
International journal of molecular sciences
|April 13, 2024
概括
基因组学独立的癌症治疗针对不同瘤类型的共同遗传改变. 虽然具有挑战性,但这种不可知论的方法是可行的,并将随着下一代测序 (NGS) 的发展而成长.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 精准医学是一门精准的医学.
背景情况:
- 瘤往往具有特定的弱点,可用于向治疗.
- 可操作的基因改变可以在各种瘤类型中共享,从而使组织学独立的治疗策略成为可能.
- 已批准的不可知疗法包括针对微卫星不稳定性 (MSI) 或高瘤突变负担 (TMB) 的免疫检查点抑制剂,NTRK/RET抑制剂和BRAF抑制剂.
研究的目的:
- 探索组织学独立或无神论的药物标匹配在癌症治疗中的可行性和不断增长的利用.
- 突出现有和潜在的基于遗传改变的不可知治疗策略.
- 讨论关于无神论癌症医学的挑战和未来方向.
主要方法:
- 审查现有文献和已批准的不可知论疗法.
- 鉴定适用于组织学独立向的基因变异 (例如,ALK/ROS1转位,BRCA1/2失活,HER2放大).
- 讨论全面下一代测序 (NGS) 在识别罕见瘤点组合中的作用.
主要成果:
- 几种不可知药物标匹配得到了临床批准,证明了该方法的有效性.
- 对于其他变异,如ALK/ROS1转位,BRCA1/2无活化和特定的HER2放大,存在不可知性向的潜力.
- 找到可用药物的目标的概率仍然相对较低,但随着NGS的采用,这种概率正在增加.
结论:
- 组织学独立的药物标匹配是瘤学中可行的,日益重要的策略.
- NGS的进步正在扩大罕见的瘤点组合的景观,这些组合可以接受无神论治疗.
- 个性化治疗决策需要仔细考虑疗效,可用性和成本,以及临床试验框架.
关键词:
人力资源副主任HRDTMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB TMB无神论的标记是不可知论的标记.激酶抑制剂 激酶抑制剂微卫星的不稳定性有针对性的治疗.更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:30Cancer Vaccines
360
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360